Your browser doesn't support javascript.
loading
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor.
Verspoor, F G M; Mastboom, M J L; Hannink, G; Maki, R G; Wagner, A; Bompas, E; Desai, J; Italiano, A; Seddon, B M; van der Graaf, W T A; Blay, J-Y; Brahmi, M; Eberst, L; Stacchiotti, S; Mir, O; van de Sande, M A J; Gelderblom, H; Cassier, P A.
Afiliación
  • Verspoor FGM; Radboud University Medical Center, Department of Orthopedics, Nijmegen, The Netherlands. FloorVerspoor@gmail.com.
  • Mastboom MJL; Leiden University Medical Center, Department of Orthopedics, Leiden, The Netherlands.
  • Hannink G; Radboud University Medical Center, Department of Operating Rooms, Nijmegen, The Netherlands.
  • Maki RG; Northwell Health/Monter Cancer Center and Cold Spring Harbor Laboratory, Department of Medical Oncology, Long Island, NY, USA.
  • Wagner A; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, USA.
  • Bompas E; Institut de Cancérologie de l'Ouest, Department of Medical Oncology, Nantes, France.
  • Desai J; Peter Mac Callum Cancer Center, Department of Medical Oncology, Melbourne, Australia.
  • Italiano A; Institut Bergonié, Department of Medical Oncology, Bordeaux, France.
  • Seddon BM; University College Hospital, Department of Medical Oncology, London, United Kingdom.
  • van der Graaf WTA; Radboud University Medical Center, Department of Medical Oncology, Nijmegen, The Netherlands.
  • Blay JY; Centre Léon Bérard, Department of Medical Oncology, Lyon, France.
  • Brahmi M; Centre Léon Bérard, Department of Medical Oncology, Lyon, France.
  • Eberst L; Centre Léon Bérard, Department of Medical Oncology, Lyon, France.
  • Stacchiotti S; Istituto Nazionale Tumori, Department of Medical Oncology, Milano, Italy.
  • Mir O; Gustave Roussy Institute, Department of Medical Oncology, Villejuif, France.
  • van de Sande MAJ; Leiden University Medical Center, Department of Orthopedics, Leiden, The Netherlands.
  • Gelderblom H; Leiden University Medical Center, Department of Medical Oncology, Leiden, The Netherlands.
  • Cassier PA; Centre Léon Bérard, Department of Medical Oncology, Lyon, France.
Sci Rep ; 9(1): 14551, 2019 10 10.
Article en En | MEDLINE | ID: mdl-31601938
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mesilato de Imatinib / Tumor de Células Gigantes de las Vainas Tendinosas / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Middle aged País/Región como asunto: America do norte / Europa / Oceania Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mesilato de Imatinib / Tumor de Células Gigantes de las Vainas Tendinosas / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Middle aged País/Región como asunto: America do norte / Europa / Oceania Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos